Inflammation

Items 11-20 of 25

Page
per page
Set Descending Direction
  1. anti-LAG-3, mAb (blocking) (11E3)
    AG-20B-0011
    AG-20B-0011-C100100 µg
    CHF 470.00
  2. anti-LAG-3, mAb (blocking) (11E3) (preservative free)
    AG-20B-0011PF
    AG-20B-0011PF-C100100 µg
    CHF 470.00
    AG-20B-0011PF-C500500 µg
    CHF 1'880.00
  3. anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14)
    AG-20B-0043
    AG-20B-0043-C100100 µg
    CHF 330.00
    Mouse neutrophils are depleted in vivo by anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (AG-20B-0043).  Method: Mice were injected) i.p. with 250µg of anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (B) or with Control mAb (A
  4. anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (Biotin)
    AG-20B-0043B
    AG-20B-0043B-C100100 µg
    CHF 360.00
  5. anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (preservative free)
    AG-20B-0043PF
    AG-20B-0043PF-C500500 µg
    CHF 350.00
    AG-20B-0043PF-M0022 mg
    CHF 590.00
    AG-20B-0043PF-M01010 mg
    CHF 1'800.00
    Reduced Prices
    Mouse neutrophils are depleted in vivo by anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (preservative free) (AG-20B-0043PF).  Method: Mice were injected) i.p. with 250µg of anti-Neutrophils (mouse), mAb (blocking) (Nimp-R14) (pre
  6. anti-NLRP3/NALP3, mAb (Cryo-2)
    AG-20B-0014
    AG-20B-0014-C100100 µg
    CHF 390.00
    Mouse NLRP3 is detected in mouse macrophages using the monoclonal antibody to NLRP3 (Cryo-2) (Prod. No. AG-20B-0014). Method: Cell extracts from mouse macrophages (BMDMs) WT +/+ (lane 1), NLRP3+/- (lane 2) or NLRP3 -/- (lane 3), with or without tre
  7. anti-NLRP3/NALP3, mAb (Cryo-2) (Biotin)
    AG-20B-0014B
    AG-20B-0014B-C05050 µg
    CHF 280.00
    anti-NLRP3/NALP3, mAb (Cryo-2) (Biotin)
  8. anti-NS3 (HCV), mAb (1B6)
    AG-20B-0001
    AG-20B-0001-C100100 µg
    CHF 400.00
  9. anti-NS5B (HCV), mAb (blocking) (5B-12B7)
    AG-20B-0003
    AG-20B-0003-C100100 µg
    CHF 400.00
  10. anti-PARP-10 [ARTD10] (human), mAb (5H11)
    AG-20T-0004
    AG-20T-0004-L0011 ml
    CHF 380.00
    Immunofluorescence using anti-PARP-10 [ARTD10] (human), mAb (5H11). Method: T47D mammary carcinoma cells were stained by indirect immunofluorescence and analysed. Prior to fixation and staining, the cells were treated with or without 50nm leptomyci

Items 11-20 of 25

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.